What does NAC do? N-acetylcysteine and what the trials show
Reviewed 29 sourcesPublished by PepVault
What NAC does: the glutathione mechanism, its approved hospital uses and what human trials found for aging, COPD, mood and fertility, as of November 2026.

- Last reviewed
- Sources
- 29
- Questions
- 11
- Compounds
- 3
The short answer
NAC (N-acetylcysteine) gives the body cysteine, the scarce building block of glutathione, its main antioxidant. Hospitals use it as the antidote for acetaminophen overdose and as an inhaled mucus thinner. As a supplement, the trials found fewer COPD flare-ups at 1,200 mg a day, less hair pulling in adults, and mixed results for glutathione in older adults. No trial shows longer life.
- NAC is a cysteine donor: it supplies one of the three building blocks of glutathione, the body's main antioxidant.
- It is an FDA-approved drug since 1963, the antidote for acetaminophen overdose, and sold as a supplement only under FDA enforcement discretion.
- The firmest supplement-level result is fewer COPD flare-ups in one 1,006-person trial; an earlier 523-person trial found none.
- GlyNAC raised glutathione in small trials from one lab; a 114-person trial in healthy older adults did not.
Evidence: Strong for the hospital uses on the label; moderate for fewer COPD flare-ups at 1,200 mg a day (one large positive trial, one negative); small and mixed trials for glutathione in aging and for psychiatric uses; lifespan only in mice.

What does NAC do in the body?
NAC is the amino acid cysteine with a small chemical cap (an acetyl group) that makes it stable. The body removes the cap and uses the cysteine to build glutathione, a three-part molecule (cysteine, glycine and glutamate) that cells use to neutralize reactive oxygen and to detoxify drugs. In the body the cap comes off quickly and leaves cysteine4, and older adults short of glutathione are short of cysteine and glycine too6.
Very little of a swallowed dose arrives intact. In healthy volunteers, 6 to 10% of a 600 mg oral dose reached the blood as NAC; the rest never arrived intact1. Measured as total NAC, it leaves the blood with a half-life of about 6 hours after an oral dose, so most of a dose is gone within a day2. That share of a dose that reaches the blood is called its bioavailability.
NAC is in PepVault's library as an oral supplement. Add it to a protocol and each day's dose is logged with one tap, at the time you take it. Log it in PepVault

What is NAC approved for?
Two hospital jobs, both on the US drug label. First, it is the antidote for acetaminophen (paracetamol, Tylenol) overdose: a large overdose uses up the liver's glutathione, a toxic breakdown product of the drug then binds to liver cells, and NAC refills the glutathione that neutralizes it4. The IV product's label gives it by weight, in three bags over 21 hours (starting at 150 mg per kg) or two bags over 20 hours3. The oral regimen on the solution's label starts at 140 mg per kg, then 70 mg per kg every 4 hours for 17 more doses4.
Timing decides how well it works. In the US study of 2,540 overdose patients treated with oral NAC, liver injury developed in 6.1% of those at probable risk when NAC started within 10 hours, and in 26.4% when it started 10 to 24 hours after the overdose5. Second, inhaled through a nebulizer, it is a mucolytic, a mucus thinner, for thick secretions in lung diseases such as emphysema and bronchitis4.
When to get help If someone may have taken too much acetaminophen, call Poison Control (1-800-222-1222 in the US) or emergency services straight away, even if they feel fine: the antidote protects the liver best when started within 8 hours3.
Does NAC raise glutathione in older adults?
In small trials from one lab, yes, when it is paired with glycine as GlyNAC. Rajagopal Sekhar's group at Baylor College of Medicine found that older adults made glutathione at about a third of young adults' daily rate, and that 2 weeks of cysteine and glycine roughly doubled their red-blood-cell glutathione6. Their 24-week pilot in 8 older adults had no placebo group7. Their randomized trial gave 12 older adults GlyNAC (100 mg per kg a day of each, about 7 g of NAC for a 70 kg person) and 12 a placebo for 16 weeks8.
| Trial | Who | Design | Result |
|---|---|---|---|
| Sekhar 20116 | 8 older and 8 young adults | 2 weeks, no placebo | Glutathione 94.6% higher; oxidative stress lower |
| Kumar 20217 | 8 older adults | 24 weeks, open label, then 12 weeks off | Glutathione restored; strength, gait and waist improved; gains faded after stopping |
| Kumar 20238 | 24 older adults (mean age 71) | 16 weeks, randomized against placebo | Glutathione 0.4 to 1.4 mmol/L; gait speed 1.13 to 1.34 m/s; grip 32.3 to 36.7 kg; placebo unchanged |
| Lizzo 20229 | 114 healthy adults, mean age 65 | 2 weeks, randomized, 3 doses against placebo | No rise in glutathione (primary endpoint); a rise only in a post hoc subgroup with low glutathione and high oxidative stress |
The two results do not cancel each other out; they describe different people and doses. The Baylor trials enrolled older adults with low glutathione at the start and gave about twice Lizzo's top NAC dose. Lizzo's trial, run by Nestlé scientists, gave 1.2 to 3.6 g of NAC a day for only 2 weeks to healthy volunteers9. A rise in glutathione is a lab number; whether it adds healthy years has not been tested.
Does NAC help you live longer?
No study in people has measured it. In genetically mixed mice at the Jackson Laboratory, NAC started at 7 months lengthened life in males only, and the authors wrote that this may have come from the mice eating less, a form of diet restriction, rather than from NAC itself10. In the Baylor lab's own study, GlyNAC-fed mice of a single strain lived 24% longer11. PepVault's longevity page (pepvault.app/longevity) puts NAC beside the other longevity supplements.
Species note: every lifespan result for NAC or GlyNAC is in mice, from single labs.
Does NAC help COPD?
Two large trials disagree, and the dose differed. BRONCUS gave 523 people with COPD 600 mg a day or placebo for 3 years: flare-ups (1.25 against 1.29 a year) and lung-function decline did not differ12. PANTHEON gave 1,006 Chinese patients with moderate to severe COPD 600 mg twice a day for a year: flare-ups fell from 1.49 to 1.16 per patient a year, a 22% drop (risk ratio 0.78), with side effects close to placebo13. The higher dose is the one with a positive result, in one trial.
Does NAC help hair pulling, addiction or mental health?
This is where NAC gets the most attention, and the results split by age and condition. The idea is that NAC rebalances glutamate, a signalling chemical, in the brain's reward circuits (shown in animals) and raises glutathione. Each first positive trial was followed by a larger or different-group trial, and most of those were negative.
| Condition | Trial | Dose | Result |
|---|---|---|---|
| Hair pulling (trichotillomania), adults | Grant 2009, 50 people, 12 weeks14 | 1,200–2,400 mg/day | 56% much improved against 16% on placebo |
| Hair pulling, children 8–17 | Bloch 2013, 39 children, 12 weeks15 | Up to 2,400 mg/day, add-on | No difference: 25% against 21% responders |
| Cannabis use, ages 15–21 | Gray 2012, 116 people, 8 weeks16 | 1,200 mg twice a day | Odds of a clean urine test 2.4 times higher |
| Cannabis use, adults 18–50 | Gray 2017, 302 people, 12 weeks17 | 1,200 mg twice a day | No difference: 22.3% against 22.4% clean tests |
| Chronic schizophrenia, add-on | Berk 2008, 140 people, 24 weeks18 | 1 g twice a day | PANSS symptom score 6 points lower than placebo |
| Early psychosis, add-on | Conus 2018, 63 people, 6 months19 | 2,700 mg/day | No change in symptoms; faster processing speed; brain glutathione up 23% |
| Bipolar depression, add-on | Berk 2008, 75 people21; Berk 2012, 149 people22; Ellegaard 2019, 80 people23 | 2–3 g/day | First trial positive; the maintenance and acute-depression trials found no difference |
A 2018 pooling of six trials (701 people) found a moderate benefit as an add-on in schizophrenia, no effect in bipolar disorder and a small effect in major depression, with side effects and dropouts similar to placebo20. In every one of these trials NAC was added to usual treatment, not used in its place.
Does NAC help the liver beyond an overdose?
In one hospital use, yes. In a trial of 173 people with acute liver failure not caused by acetaminophen, a 72-hour NAC drip did not change overall survival at 3 weeks (70% against 66%) but raised survival without a transplant from 27% to 40%. The gain was confined to people in early stages (52% against 30%); nausea and vomiting were more common on NAC (14% against 4%)24. That is IV NAC in intensive care, not a capsule.
Does NAC help fertility?
In polycystic ovary syndrome (PCOS), a 2015 review of 8 trials with 910 women found NAC raised the odds of ovulation and pregnancy against placebo, in two trials alongside the fertility drug clomiphene, but did worse than metformin on both25. Most trials used 1,800 mg a day. The reviewers rated several trials at high risk of bias, and live birth came from a single 60-woman trial.
Can an antioxidant like NAC feed a tumor?
In mice with lung cancer, it sped tumors up. NAC and vitamin E in the diet increased tumor growth and shortened survival in mouse models of lung cancer, because tumor cells also benefit when oxidative stress is lowered26. No human trial has shown this, and none has ruled it out.
Species note: the tumor result is in mice; the authors raised it as a question for smokers and people with COPD, not as a human finding.
Is NAC legal to sell as a supplement?
Yes, under an FDA policy of not enforcing, as of November 2026. NAC was approved as a drug on September 14, 1963, and US law keeps an ingredient approved as a drug first out of the supplement definition. In July 2020 FDA cited that rule in a warning letter to a company selling NAC in a hangover product27. After industry petitions, FDA's final guidance of August 2022 said it will not act against NAC labeled as a supplement unless the product breaks other rules or claims to treat a disease28. In November 2023 FDA finished its own safety review and sent it to peer review; its page has no later update29.
How much NAC did the trials use?
From 600 mg to about 7 g a day, by condition. These are the doses studied, not a recommendation: 600 mg a day in the negative COPD trial and 1,200 mg a day in the positive one1213, 1,200 to 2,400 mg in the hair-pulling trials1415, 2,000 to 3,000 mg in the psychiatric add-on trials1823, 1,800 mg in most PCOS trials25, and 1.2 to 3.6 g, or 100 mg per kg, in the GlyNAC trials98. Because it clears within hours, most trials split it into two or three doses.
Commonly reported: nothing felt day to day; a sulfur smell from the capsules; mild stomach upset or nausea in some. In the oral trials above, side effects ran close to placebo1320.
If you take a prescription medicine, adding NAC is a decision to make with your prescriber.
Set NAC to twice a day in PepVault and Today shows both doses, so a split like the trials' is logged as two doses rather than one. Set a dose time and the app reminds you if it is not logged. Set reminders in PepVault
Sources
- Borgström L et al. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol. 1986. PubMed 3803419
- Olsson B et al. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol. 1988. PubMed 3360052
- ACETADOTE (acetylcysteine) injection, prescribing information. Cumberland Pharmaceuticals. DailyMed, published July 30, 2025. dailymed.nlm.nih.gov
- Acetylcysteine solution (inhalation and oral antidote), prescribing information. Hospira. DailyMed, published May 25, 2026. dailymed.nlm.nih.gov
- Smilkstein MJ et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988. PubMed 3059186
- Sekhar RV et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011. PubMed 21795440
- Kumar P et al. Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults: results of a pilot clinical trial. Clin Transl Med. 2021. PubMed 33783984
- Kumar P et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023. PubMed 35975308
- Lizzo G et al. A randomized controlled clinical trial in healthy older adults to determine efficacy of glycine and N-acetylcysteine supplementation on glutathione redox status and oxidative damage. Front Aging. 2022. PubMed 35821844
- Flurkey K et al. Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2010. PubMed 20819793
- Kumar P et al. GlyNAC (glycine and N-acetylcysteine) supplementation in mice increases length of life. Nutrients. 2022. PubMed 35268089
- Decramer M et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (BRONCUS): a randomised placebo-controlled trial. Lancet. 2005. PubMed 15866309
- Zheng JP et al. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2014. PubMed 24621680
- Grant JE et al. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009. PubMed 19581567
- Bloch MH et al. N-acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013. PubMed 23452680
- Gray KM et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012. PubMed 22706327
- Gray KM et al. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017. PubMed 28623823
- Berk M et al. N-acetyl cysteine as a glutathione precursor for schizophrenia: a double-blind, randomized, placebo-controlled trial. Biol Psychiatry. 2008. PubMed 18436195
- Conus P et al. N-acetylcysteine in a double-blind randomized placebo-controlled trial: toward biomarker-guided treatment in early psychosis. Schizophr Bull. 2018. PubMed 29462456
- Zheng W et al. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials. Acta Psychiatr Scand. 2018. PubMed 29457216
- Berk M et al. N-acetyl cysteine for depressive symptoms in bipolar disorder: a double-blind randomized placebo-controlled trial. Biol Psychiatry. 2008. PubMed 18534556
- Berk M et al. Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial. BMC Med. 2012. PubMed 22891797
- Ellegaard PK et al. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: a randomized placebo-controlled study. J Affect Disord. 2019. PubMed 30699846
- Lee WM et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009. PubMed 19524577
- Thakker D et al. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int. 2015. PubMed 25653680
- Sayin VI et al. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014. PubMed 24477002
- US FDA. Warning letter to LES Labs (hangover products, NAC), July 23, 2020. fda.gov
- US FDA. Policy regarding N-acetyl-L-cysteine: guidance for industry. August 2022. fda.gov
- US FDA. FDA releases final guidance on enforcement discretion for certain NAC products (constituent update, August 1, 2022; updated November 29, 2023). fda.gov
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.